Integer Holdings Corp revenue
Integer Holdings Corp's revenue was $1.85bn in fiscal 2025, up 8.0% on the year before. Since fiscal 2009 ($522m) it has grown at a compound 8.2% a year. Over the last twelve months it was $1.83bn.
Revenue history
| Fiscal year | 2009Jan 2010 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Jan 2014 | 2014Jan 2015 | 2015Jan 2016 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMOct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 522 | 533 | 569 | 646 | 664 | 688 | 800 | 1,076 | 1,136 | 1,215 | 1,258 | 1,073 | 1,221 | 1,331 | 1,556 | 1,717 | 1,854 | 1,825 |
| Growth on the year before | — | +2.2% | +6.6% | +13.6% | +2.7% | +3.6% | +16.4% | +34.4% | +5.6% | +6.9% | +3.5% | −14.7% | +13.8% | +9.0% | +16.9% | +10.3% | +8.0% | — |
| Gross profit | 166 | 174 | 180 | 202 | 219 | 231 | 235 | 338 | 354 | 363 | 355 | 286 | 337 | 346 | 410 | 459 | 500 | 449 |
| Gross margin | 31.9% | 32.5% | 31.7% | 31.2% | 33.0% | 33.6% | 29.4% | 31.4% | 31.2% | 29.8% | 28.2% | 26.6% | 27.6% | 26.0% | 26.3% | 26.7% | 27.0% | 24.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Cardio and Vascular | $1.1B | 59.7% | ▲ 16.6% |
| Cardiac Rhythm Management Neuromodulation | $669M | 36.1% | ▲ 1.2% |
| Other Markets | $77.8M | 4.2% | ▼ 26.9% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $980M | 52.9% | ▲ 4.4% |
| Rest of World | $470M | 25.3% | ▲ 8.8% |
| CR | $174M | 9.4% | ▲ 39.2% |
| PR | $131M | 7.1% | ▼ 4.2% |
| Ireland | $99.2M | 5.3% | ▲ 17.5% |
From Integer Holdings Corp's 10-K filed February 23, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Integer Holdings Corp | $1.83bn | -0.3% | 6.7% |
| Integra Lifesciences Holdings Corp | $1.66bn | 0.8% | 2.4% |
| Merit Medical Systems Inc | $1.61bn | 9.1% | 9.5% |
| Penumbra Inc | $1.56bn | 17.0% | 16.2% |
| Teleflex Inc | $2.25bn | 30.7% | -8.0% |
| Enovis Corp | $2.30bn | 4.9% | 12.2% |
Compare with peers
- Integra Lifesciences Holdings Corp revenue
- Merit Medical Systems Inc revenue
- Penumbra Inc revenue
- Teleflex Inc revenue
- Enovis Corp revenue
Head to head: IART vs ITGRITGR vs MMSIITGR vs PENITGR vs TFX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies